102 related articles for article (PubMed ID: 19380385)
1. The effect of weight loss on anti-Müllerian hormone levels in overweight and obese women with polycystic ovary syndrome and reproductive impairment.
Thomson RL; Buckley JD; Moran LJ; Noakes M; Clifton PM; Norman RJ; Brinkworth GD
Hum Reprod; 2009 Aug; 24(8):1976-81. PubMed ID: 19380385
[TBL] [Abstract][Full Text] [Related]
2. The effect of liraglutide on weight loss in women with polycystic ovary syndrome: an observational study.
Rasmussen CB; Lindenberg S
Front Endocrinol (Lausanne); 2014; 5():140. PubMed ID: 25221543
[TBL] [Abstract][Full Text] [Related]
3. Impact of hypocaloric dietary intervention on ovulation in obese women with PCOS.
Jarrett BY; Lujan ME
Reproduction; 2016 Oct; ():. PubMed ID: 27799625
[TBL] [Abstract][Full Text] [Related]
4. Expression of concern: 'The effects of dietary approaches to stop hypertension diet on weight loss, anti-Müllerian hormone and metabolic profiles in women with polycystic ovary syndrome: A randomized clinical trial'.
Clin Endocrinol (Oxf); 2024 Jun; 100(6):594. PubMed ID: 38409915
[No Abstract] [Full Text] [Related]
5. Obesity adversely affects serum anti-müllerian hormone (AMH) levels in Caucasian women.
Moy V; Jindal S; Lieman H; Buyuk E
J Assist Reprod Genet; 2015 Sep; 32(9):1305-11. PubMed ID: 26194744
[TBL] [Abstract][Full Text] [Related]
6. Characterization of women with elevated antimüllerian hormone levels (AMH): correlation of AMH with polycystic ovarian syndrome phenotypes and assisted reproductive technology outcomes.
Tal R; Seifer DB; Khanimov M; Malter HE; Grazi RV; Leader B
Am J Obstet Gynecol; 2014 Jul; 211(1):59.e1-8. PubMed ID: 24593938
[TBL] [Abstract][Full Text] [Related]
7. Diet, physical exercise and Orlistat administration increase serum anti-Müllerian hormone (AMH) levels in women with polycystic ovary syndrome (PCOS).
Vosnakis C; Georgopoulos NA; Rousso D; Mavromatidis G; Katsikis I; Roupas ND; Mamali I; Panidis D
Gynecol Endocrinol; 2013 Mar; 29(3):242-5. PubMed ID: 23194076
[TBL] [Abstract][Full Text] [Related]
8. Is the plasma anti-Müllerian hormone (AMH) level associated with body weight and metabolic, and hormonal disturbances in women with and without polycystic ovary syndrome?
Skałba P; Cygal A; Madej P; Dąbkowska-Huć A; Sikora J; Martirosian G; Romanik M; Olszanecka-Glinianowicz M
Eur J Obstet Gynecol Reprod Biol; 2011 Oct; 158(2):254-9. PubMed ID: 21752527
[TBL] [Abstract][Full Text] [Related]
9. The relationships between AMH, androgens, insulin resistance and basal ovarian follicular status in non-obese subfertile women with and without polycystic ovary syndrome.
Nardo LG; Yates AP; Roberts SA; Pemberton P; Laing I
Hum Reprod; 2009 Nov; 24(11):2917-23. PubMed ID: 19617605
[TBL] [Abstract][Full Text] [Related]
10. Obesity Does not Compromise Ovarian Reserve Markers in Infertile Women.
Gorkem U; Kucukler FK; Togrul C; Gulen Ş
Geburtshilfe Frauenheilkd; 2019 Jan; 79(1):79-85. PubMed ID: 30686837
[No Abstract] [Full Text] [Related]
11. The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.
Rosenfield RL; Ehrmann DA
Endocr Rev; 2016 Oct; 37(5):467-520. PubMed ID: 27459230
[TBL] [Abstract][Full Text] [Related]
12. Is there any correlation between amh and obesity in premenopausal women?
Sahmay S; Usta T; Erel CT; Imamoğlu M; Küçük M; Atakul N; Seyisoğlu H
Arch Gynecol Obstet; 2012 Sep; 286(3):661-5. PubMed ID: 22552379
[TBL] [Abstract][Full Text] [Related]
13. Endocrine consequences of weight loss in obese, hyperandrogenic, anovulatory women.
Guzick DS; Wing R; Smith D; Berga SL; Winters SJ
Fertil Steril; 1994 Apr; 61(4):598-604. PubMed ID: 8150098
[TBL] [Abstract][Full Text] [Related]
14. The effect of weight loss program on serum anti-Müllerian hormone level in obese and overweight infertile women with polycystic ovary syndrome.
Moini A; Arabipoor A; Hemat M; Ahmadi J; Salman-Yazdi R; Zolfaghari Z
Gynecol Endocrinol; 2019 Feb; 35(2):119-123. PubMed ID: 30580636
[TBL] [Abstract][Full Text] [Related]
15. The physiology and clinical utility of anti-Mullerian hormone in women.
Dewailly D; Andersen CY; Balen A; Broekmans F; Dilaver N; Fanchin R; Griesinger G; Kelsey TW; La Marca A; Lambalk C; Mason H; Nelson SM; Visser JA; Wallace WH; Anderson RA
Hum Reprod Update; 2014; 20(3):370-85. PubMed ID: 24430863
[TBL] [Abstract][Full Text] [Related]
16. Serum antimüllerian hormone in response to dietary management and/or physical exercise in overweight/obese women with polycystic ovary syndrome: secondary analysis of a randomized controlled trial.
Nybacka Å; Carlström K; Fabri F; Hellström PM; Hirschberg AL
Fertil Steril; 2013 Oct; 100(4):1096-102. PubMed ID: 23876536
[TBL] [Abstract][Full Text] [Related]
17. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome.
Teede HJ; Misso ML; Costello MF; Dokras A; Laven J; Moran L; Piltonen T; Norman RJ;
Hum Reprod; 2018 Sep; 33(9):1602-1618. PubMed ID: 30052961
[TBL] [Abstract][Full Text] [Related]
18. Effect of High Fat Diet on Disease Development of Polycystic Ovary Syndrome and Lifestyle Intervention Strategies.
Han Y; Wu H; Sun S; Zhao R; Deng Y; Zeng S; Chen J
Nutrients; 2023 May; 15(9):. PubMed ID: 37432488
[TBL] [Abstract][Full Text] [Related]
19. Adherence to the Mediterranean Diet in Women and Reproductive Health across the Lifespan: A Narrative Review.
Szmidt MK; Granda D; Madej D; Sicinska E; Kaluza J
Nutrients; 2023 Apr; 15(9):. PubMed ID: 37432245
[TBL] [Abstract][Full Text] [Related]
20. Ketogenic Diet as Medical Prescription in Women with Polycystic Ovary Syndrome (PCOS).
Barrea L; Verde L; Camajani E; Cernea S; Frias-Toral E; Lamabadusuriya D; Ceriani F; Savastano S; Colao A; Muscogiuri G
Curr Nutr Rep; 2023 Mar; 12(1):56-64. PubMed ID: 36695999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
